Glenmark redeems bonds totaling US$75 million principal amount
On April 7, 2022, Glenmark Pharmaceuticals repurchased an aggregate principal amount of $75,000,000 of the $200,000,000 of 2.00% Resettable Equity Linked Securities due 2022 (ISIN: XS1426780125; Common Code: 142678012) (Bonds) (Redemption).
The Repurchase was effected by way of market purchases via The Hongkong and Shanghai Banking Corporation.
The Bonds are listed on the Singapore Exchange Securities Trading.
Settlement and cancellation of the redeemed Bonds was completed on April 7, 2022. Following cancellation, the outstanding principal amount of the Bonds will be USD 750,000.
Powered by Capital Market – Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)